Viral hepatitis presents a significant opportunity for progress within European health policy, given the availability of effective tools for prevention, diagnosis, and treatment. At the same time, important challenges remain in ensuring that these tools are implemented equitably and at scale across Europe. Persistent differences between countries remain in early detection efforts, continuity of care, access to essential diagnostic tools, and the availability of high-quality data to support informed decision-making.

Addressing these challenges will require strengthening the consistency and comparability of evidence across Member States, alongside more integrated and sustained policy dialogue among researchers, clinicians, patient organisations, and decision-makers. The HOPE Policy Roundtables respond to both the opportunity and the challenge by providing a structured forum for exchange, promoting best practices, and translating scientific evidence into clear, actionable policy recommendations.

The Viral HOPE Policy Roundtables are designed as a targeted policy platform to advance a set of interconnected strategic objectives that support Europe’s progress toward viral hepatitis elimination and reinforce liver health as a public health priority.

Position liver health within EU public health priorities

Advocate for integrating viral hepatitis elimination into European health policies, highlighting the clinical, economic, and societal benefits and ensuring equitable access to screening and treatment.

Accelerate evidence-based pathways for elimination

Showcase EASL’s scientific leadership in developing and disseminating best practices for screening, linkage to care, and micro-elimination strategies.

Strengthen political commitment and resource mobilisation

Advocate for high-level support for EU-wide coordination and measurable targets to meet the 2030 WHO elimination goal, positioning EASL as a key partner.